Kwang Soo

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 352 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

Bon‐Kwon Koo, Jeehoon Kang, Kyung Woo Park et al. · The Lancet · 2021 · 322 citations

Thrombosis, Percutaneous Coronary Intervention, Chronic Maintenance Monotherapy +11

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Safety and Effect of Adipose Tissue-Derived Stem Cell Implantation in Patients With Critical Limb Ischemia

Han Cheol Lee, Sung Gyu An, Hye Won Lee et al. · Circulation Journal · 2012 · 274 citations · Full text

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Chan Joon Kim, Mahn‐Won Park, Min Chul Kim et al. · The Lancet · 2021 · 177 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12